Resultats de la cerca - Idbaih, Ahmed
- Mostrar 1 - 20 resultats de 119
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
ACTR-39. APPLICATION OF RTOG-RPA SCORES IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE (TTFIELDS/TMZ) VERSUS TEMOZOLOMIDE (TMZ) ALONE IN NEWLY DIAGNOSED GLIOBLASTOMA... per Choe, Kevin, Idbaih, Ahmed, Taillibert, Sophie, Escuder, Jordi Bruna, Sroubek, Jan, Kanner, Andrew
Publicat 2017Text -
5
-
6
-
7
-
8
Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial per Ram, Zvi, Kim, Chae-Yong, Hottinger, Andreas F., Idbaih, Ahmed, Nicholas, Garth, Zhu, Jay-Jiguang
Publicat 2021Text -
9
Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial per Ram, Zvi, Kim, Chae-Yong, Hottinger, Andreas F., Idbaih, Ahmed, Nicholas, Garth, Zhu, Jay-Jiguang
Publicat 2022Text -
10
Phenotypic selection through cell death: stochastic modelling of O-6-methylguanine-DNA methyltransferase dynamics per Lasri, Ayoub, Juric, Viktorija, Verreault, Maité, Bielle, Franck, Idbaih, Ahmed, Kel, Alexander, Murphy, Brona, Sturrock, Marc
Publicat 2020Text -
11
Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors per Alphandéry, Edouard, Idbaih, Ahmed, Adam, Clovis, Delattre, Jean-Yves, Schmitt, Charlotte, Gazeau, Florence, Guyot, François, Chebbi, Imène
Publicat 2019Text -
12
Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy per Haroche, Julien, Cohen Aubart, Fleur, Mokhtari, Karima, Seilhean, Danielle, Benameur, Neila, Peyre, Matthieu, Idbaih, Ahmed, Amoura, Zahir
Publicat 2021Text -
13
-
14
Manifestations cliniques et facteurs pronostiques de la COVID-19 chez les patients souffrant de gliome diffus per Lozano, Fernando, Ursu, Renata, Stefano, Anna Luisa Di, Ducray, François, Younan, Nadia, Touat, Mehdi, Carpentier, Antoine, Idbaih, Ahmed
Publicat 2021Text -
15
Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic... per Vessières, Anne, Quissac, Emie, Lemaire, Nolwenn, Alentorn, Agusti, Domeracka, Patrycja, Pigeon, Pascal, Sanson, Marc, Idbaih, Ahmed, Verreault, Maïté
Publicat 2021Text -
16
Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patients per Le Rhun, Emilie, Chamberlain, Marc C, Zairi, Fahed, Delmaire, Christine, Idbaih, Ahmed, Renaud, Florence, Maurage, Claude Alain, Grégoire, Valérie
Publicat 2015Text -
17
Temporary disruption of the blood-brain barrier using an implantable ultrasound system for recurrent glioblastoma patients under IV carboplatin chemotherapy: initial phase 1/2a cli... per Carpentier, Alexandre, Canney, Michael, Vignot, Alexandre, Horodyckid, Catherine, Goldwirt, Lauriane, Leclercq, Delphine, Delattre, Jean-Yves, Chapelon, Jean-Yves, Idbaih, Ahmed
Publicat 2015Text -
18
Histiocytosis and the nervous system: from diagnosis to targeted therapies per Cohen Aubart, Fleur, Idbaih, Ahmed, Emile, Jean-François, Amoura, Zahir, Abdel-Wahab, Omar, Durham, Benjamin H, Haroche, Julien, Diamond, Eli L
Publicat 2021Text -
19
CNS inflammatory disorder after concurrent radiotherapy-temozolomide and nivolumab in a glioblastoma patient per Di Stefano, Anna Luisa, Savatovsky, Julien, Feuvret, Loic, Villa, Chiara, Reina, Vincent, Pha, Micheline, Houillier, Caroline, Berzero, Giulia, Idbaih, Ahmed, Psimaras, Dimitri
Publicat 2019Text -
20
Therapeutic potential of parkin as a tumor suppressor via transcriptional control of cyclins in glioblastoma cell and animal models per Rouland, Lila, Duplan, Eric, Ramos dos Santos, Lígia, Bernardin, Aurore, Katula, Karen S., Manfioletti, Guidalberto, Idbaih, Ahmed, Checler, Frédéric, Alves da Costa, Cristine
Publicat 2021Text